A2 Milk results set the stage for further growth
Head of Equity Strategy
We maintain our positive view on the stock based on the FY'18 result.
Management says it anticipates further growth in FY'19 driven by Australia, New Zealand, China. and US markets. The company has a 34.7% return on invested capital against cost of capital at 13.4% translating into a healthy profitability spread for shareholders. A2 Milk will in our view continue to be an attractive long-term growth story in Asia in an interesting product category. The infant formula segment in particular is expected to grow quickly in China.
A2 Milk continues to have a high score in our Equity Radar model (+0.47) driven by very high quality (return on capital), zero leverage on the balance sheet, and very high momentum.
The risks are a stronger AUD, a weaker Chinese economy, research showing little healthy effects from a2 proteins in a2 milk, and lower operating margins from increased competition.
Latest Market Insights
Quarterly Outlook Q2 2022: The End Game has arrived
Productivity and innovation have never been more important
The great EUR recovery and the difficulty of trading it
Tight commodity markets – turbocharged by war and sanctionsWith supply already tight, commodities keep powering on. But will it last for yet another quarter?
Between a rock and a hard place
The Great Erosion
Cybersecurity – the rush to catch up with reality
Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-gb/legal/disclaimer/saxo-disclaimer)